Inhibition of the proteasome activity, a novel mechanism associated with the tumor cell apoptosis-inducing ability of genistein.
about
Novel epigallocatechin gallate analogs as potential anticancer agents: a patent review (2009 - present)Computational Approaches for the Discovery of Human Proteasome Inhibitors: An OverviewThe Potential of Plant Phenolics in Prevention and Therapy of Skin DisordersSoy Isoflavones and Breast Cancer Cell Lines: Molecular Mechanisms and Future PerspectivesSynthesis and biological evaluation of naphthoquinone analogs as a novel class of proteasome inhibitorsEffects of genistein supplementation on genome‑wide DNA methylation and gene expression in patients with localized prostate cancerSafety and chemopreventive effect of Polyphenon E in preventing early and metastatic progression of prostate cancer in TRAMP mice.Inhibition of cancer cell invasion and metastasis by genisteinDietary soy and tea mitigate chronic inflammation and prostate cancer via NFκB pathway in the Noble rat modelPregnancy is associated with decreased cardiac proteasome activity and oxidative stress in mice.Apoptosis by dietary agents for prevention and treatment of prostate cancerProceedings of the Indo-U.S. bilateral workshop on accelerating botanicals/biologics agent development research for cancer chemoprevention, treatment, and survivalResults of a randomized phase I dose-finding trial of several doses of isoflavones in men with localized prostate cancer: administration prior to radical prostatectomy.Prostate Cancer Chemoprevention Targeting High Risk Populations: Model for Trial Design and Outcome Measures.Natural compounds with proteasome inhibitory activity for cancer prevention and treatment.The ubiquitin-proteasome system as a prospective molecular target for cancer treatment and prevention.Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives.Novel epigallocatechin gallate (EGCG) analogs activate AMP-activated protein kinase pathway and target cancer stem cells.Targeting tumor ubiquitin-proteasome pathway with polyphenols for chemosensitization.Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention.Nano-liquid Chromatography-orbitrap MS-based Quantitative Proteomics Reveals Differences Between the Mechanisms of Action of Carnosic Acid and Carnosol in Colon Cancer Cells.Curcumin inhibits Rift Valley fever virus replication in human cells.Broad targeting of resistance to apoptosis in cancer.The soybean peptide lunasin promotes apoptosis of mammary epithelial cells via induction of tumor suppressor PTEN: similarities and distinct actions from soy isoflavone genisteinA Phase II randomized, placebo-controlled clinical trial of purified isoflavones in modulating steroid hormones in men diagnosed with localized prostate cancer.Safety of purified isoflavones in men with clinically localized prostate cancerFrom bortezomib to other inhibitors of the proteasome and beyond.Chemical genetics: exploring the role of the proteasome in cell biology using natural products and other small molecule proteasome inhibitors.Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cellsMulti-targeted therapy of cancer by genisteinGenistein targets the cancerous inhibitor of PP2A to induce growth inhibition and apoptosis in breast cancer cells.Clinical development of novel proteasome inhibitors for cancer treatment.Isoflavones and the prevention of breast and prostate cancer: new perspectives opened by nutrigenomics.Shikonin exerts antitumor activity via proteasome inhibition and cell death induction in vitro and in vivo.Natural polyphenols as proteasome modulators and their role as anti-cancer compounds.Genistein Induces Apoptosis and Inhibits Proliferation of HT29 Colon Cancer CellsMolecular Targeted Therapies Using Botanicals for Prostate Cancer Chemoprevention.The natural dietary genistein boosts bacteriophage-mediated cancer cell killing by improving phage-targeted tumor cell transduction.Analytical and compositional aspects of isoflavones in food and their biological effects.Soy isoflavones and prostate cancer: a review of molecular mechanisms.
P2860
Q24595211-62A61A23-8BF7-4061-B5F6-2E4247D2D336Q26738752-FFE674E0-D79F-4B85-A0DF-5FC035D826D3Q26768462-521392C2-522F-4BD7-9229-23078F760D4BQ26772042-53112B26-189F-481A-8DE0-1913E435DD5AQ33629972-F41D421C-4906-4A1C-9DED-0D8C50C899A8Q33787995-2C5742CB-98DF-4BD6-BA55-397DA5F8E257Q34008178-CB19BFD0-8409-4022-9C21-19ADAF92E932Q34105995-3C22DB1A-1B0F-4A7B-B4DF-EE2A2610F9BDQ34372606-C6DDCECE-B136-456D-8F19-F51B6D4559EDQ34481968-22A052A9-C4B5-46D5-9222-84148134FDBFQ34614042-B381E289-F9DB-4123-A4A4-79C28054F50FQ35054256-7BAD8A52-1D34-469B-8759-692360039D5EQ35752245-BEDEED67-C3BA-43A5-857F-376BF0785480Q35823852-207EF43D-511A-4756-9A85-7E3D58D25CB9Q35828472-DDB5E088-5E5A-48AA-9596-5173C688DB07Q35836872-5C1DA878-A359-4B62-9672-31976D4CC5AEQ35836881-6FB8302A-26D9-4990-ADE9-FB3A0B3D7257Q35907038-D5EEAC7A-F988-4160-A0C2-4D4E8FE0E920Q36037180-CFFB4187-6F3B-422F-B10F-D7B0B490EF0EQ36132629-1751DDED-41E2-4089-97E0-2F88ADE3071AQ36189599-29433E73-EFCA-4C8C-8932-8C1FD8152E89Q36286082-05F04AEE-7C1D-4EBB-B874-2AC3665E6152Q36483749-982F33EE-680C-4168-92EC-30D907380A64Q36502037-A64BF82A-3E7A-47A0-8975-5189628A739CQ36732271-65B0BE25-EDD5-4173-81D7-7EAD3651B0B5Q36741928-C3AEA2E9-7669-477E-AEA0-17667040CBB5Q36852277-ACB3C2A1-0678-4680-B3FB-E65923023824Q36915734-34EE8939-3C67-4954-9421-C43C11E25EFAQ36924212-EB85956E-EF42-4B83-91F5-F2827559B08BQ36955543-08623C6F-297A-425B-9D4B-E69650FC4563Q37103978-FE8977DE-6E0A-49B3-B5EE-1193257723CCQ37136598-F0166FCC-1652-4286-8A60-F7F5AF852D56Q37173328-77FE317E-98A2-45BF-84F5-1C575F9185ACQ37254808-EE9041F8-D53F-401A-B4F7-024F64B27A86Q37311396-9E1C0762-8D90-4485-8060-A73C24B351EBQ37445469-C83ECA7A-41CC-4031-B036-402A99442D43Q37576761-28B98897-21DA-486A-8AD0-4DE393732488Q37588421-E55F97D7-6C7E-461E-96C9-006449945D42Q37602049-CFD37535-4680-4707-B048-2393A9F568A6Q37654590-9FC2242F-EED2-4366-B875-622FA9BB9D3D
P2860
Inhibition of the proteasome activity, a novel mechanism associated with the tumor cell apoptosis-inducing ability of genistein.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Inhibition of the proteasome a ...... inducing ability of genistein.
@ast
Inhibition of the proteasome a ...... inducing ability of genistein.
@en
type
label
Inhibition of the proteasome a ...... inducing ability of genistein.
@ast
Inhibition of the proteasome a ...... inducing ability of genistein.
@en
prefLabel
Inhibition of the proteasome a ...... inducing ability of genistein.
@ast
Inhibition of the proteasome a ...... inducing ability of genistein.
@en
P2093
P1476
Inhibition of the proteasome a ...... inducing ability of genistein.
@en
P2093
Aslamuzzaman Kazi
David M Smith
Kenyon G Daniel
Nagi B Kumar
Q Ping Dou
P304
P356
10.1016/S0006-2952(03)00414-3
P407
P577
2003-09-01T00:00:00Z